J. A. McKnight

Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial.

Philip J. Bergman, J. A. McKnight, Andrew Novosad et al. · PubMed · 2003 · 331 citations

Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center

Philip J. Bergman, M. A. Camps‐Palau, J. A. McKnight et al. · Vaccine · 2005 · 291 citations

Vaccination, Veterinary Vaccine, Xenotransplantation +11

Retrospective Evaluation of Adjunctive Doxorubicin for the Treatment of Feline Mammary Gland Adenocarcinoma: 67 Cases

C. Andrew Novosad, Philip J. Bergman, Maura G. O’Brien et al. · Journal of the American Animal Hospital Association · 2006 · 77 citations

Survival Time, Surgical Oncology, Medical Records +12

Treatment of canine mast cell tumours with vinblastine, cyclophosphamide and prednisone: 35 cases (1997–2004)

M. A. Camps‐Palau, Nicole F. Leibman, Robyn Elmslie et al. · Veterinary and Comparative Oncology · 2007 · 53 citations

Medicine, Mast Cell Disorder, Veterinary Pathology +14

Evaluation of intracavitary mitoxantrone and carboplatin for treatment of carcinomatosis, sarcomatosis and mesothelioma, with or without malignant effusions: A retrospective analysis of 12 cases (1997–2002)*

Sarah C. Charney, Philip J. Bergman, J. A. McKnight et al. · Veterinary and Comparative Oncology · 2005 · 40 citations

Intracavitary Mitoxantrone, Surgical Oncology, Cancer Therapeutics +15